Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.192EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.192ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.192ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.192EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.192EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.192ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.192ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.39.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.39.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.39.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.39.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.39.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.39.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.39.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.39.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DY.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KP.2.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KP.2.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KP.2.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KP.2.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.2.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LJ.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LJ.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LJ.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LJ.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
LJ.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
LJ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LJ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LE.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LE.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LE.1.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LE.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LE.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
LE.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
LE.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LE.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MD.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-3774.92South Korea
MD.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-2361.24South Korea
MD.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-2824.15Germany
MD.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3196.01Germany
MD.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-3064.43China
MD.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
MD.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-2013.34China
MD.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.1.16EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.5.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used